Short seller accuses GenScript of CAR T data fraud

GenScript Biotech Corp. (HKSE:1548) shed HK$4.34 (27%) to HK$11.86 before halting trading on Sept. 27 after a report published by short seller Flaming Research accused the company of manipulating data and concealing safety issues during clinical development of CAR T therapy JNJ-68284528 (LCAR-B38M).

Flaming Research describes itself on its website as an organization

Read the full 529 word article

User Sign In